(600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 17th Extraordinary Meeting of the 9th Board of Directors
Filed with SSE · Stock code 600521 · · 2 pages · Chinese
Summary by 6ix AI
The board approved a proposal for increasing capital and introducing investors for its subsidiary, Shanghai Huatai Biopharmaceutical Co., Ltd.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Zhejiang Huahai Pharmaceutical Co., Ltd. on 6ix
Story so far
- (600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 16th Extraordinary Meeting of the 9th Board of Directors
- (600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Capital Increase in Investee Company and Related Party Transactions
- (600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Conversion Results of Convertible Corporate Bonds and Share Changes
Earlier from Zhejiang Huahai Pharmaceutical
- (600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 16th Extraordinary Meeting of the 9th Board of Directors
- (600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Capital Increase in Investee Company and Related Party Transactions
- (600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Conversion Results of Convertible Corporate Bonds and Share Changes
- (600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Estimated Increase in Performance for the First Three Quarters of 2026
- Announcement on Progress in Providing Guarantee for Subsidiary
Later from Zhejiang Huahai Pharmaceutical
- (600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Obtaining Drug Registration Certificate
- (600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Redemption at Maturity and Delisting of "HUAHAI Convertible Bonds"
Follow Zhejiang Huahai Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Huahai Pharmaceutical